Pfizer has announced a multi-year cost-cutting program focusing on operational efficiencies, network structure changes, and product portfolio enhancements, aiming to save $1.5 billion by 2027 amidst declining COVID-19 vaccine sales.

Pfizer and AstraZeneca have announced massive investments in France totaling nearly $1 billion. Two major pharmaceutical companies, Pfizer and AstraZeneca, announced on Sunday massive investments in France totaling nearly $1 billion.

Pfizer has agreed to settle over 10,000 lawsuits concerning the alleged connection between its product, Zantac, and cancer.

Pfizer has agreed to settle over 10,000 lawsuits concerning its Zantac heartburn medication after it was found that a cancer risk was not disclosed.

A recent study conducted by the Centers for Disease Control and Prevention (CDC) has revealed that there is no link between COVID-19 vaccines and cardiac death in younger adults.

Pfizer is shifting its focus from COVID-related products to cancer drugs. Pfizer is shifting its focus on cancer drugs as the pharmaceutical giant tries to recover from a challenging period due to the decline of its COVID-19 business.

The cancer therapy was revealed during the Innovation Day event to engage investors and strengthen its position in cancer research and treatment.

Pfizer has agreed to pay $93 million to resolve antitrust claims by wholesale drug distributors accusing the pharmaceutical giant of conspiring with India's Ranbaxy Laboratories to delay the sales of cheaper versions of the cholesterol drug Lipitor.

Several major drug companies, including Pfizer, Sanofi, and Takeda Pharmaceutical, are gearing up to implement price hikes on over 500 drugs in the United States in early January.

Pharmaceutical giant Pfizer said it is set to finalize its $43 billion acquisition of cancer drugmaker Seagen this week.